A scoring system based on the percentage of positive cells and the intensity of staining was applied for the semiquantitative assessment of EG-VEGF, as negative or positive.
Statistics ovarian cancer vegf c2 test, and Kaplan-Meier and log-rank test. Our data confirmed the predominance of EG-VEGF positivity in the serous subtype as compared to endometrioid and clear cell subtypes, and its absence in mucinous subtype.
Ovarian cancer vegf, Bevacizumab (Avastin)
Significant differences were registered between the EG-VEGF positive or negative expression and tumor stage and histological subtypes, respectively. Conclusions: The analysis of EG-VEGF expression in ovarian tumors points out the relationship between the enhanced potential for tumor angiogenesis and the tumor ovarian cancer vegf.
Developing nervous tissue induces formation of blood-brain barrier character-istics in invading endothelial cells: a study using quail--chick transplantation chimeras. Dev Biol ; 84 1 : LeCouter J. Identification of an angiogenic mitogen selective for endocrine gland endothelium. Nature ; : — Brouillet S.
Mol Biol Cell15; 21 16 Endocrine gland-derived vascular endothelial growth factor strengthens cell invasion ability via prokineticin receptor 2 in colon cancer cell lines.
Oncol Rep ; 29 2 : Expression and localization of endocrine gland-derived vascular endothelial growth factor EG-VEGF in human pancreas and pancreatic adenocarcinoma. Expression of endocrine gland-derived vascular endothelial growth factor in ovarian carci-noma. Localization and quantification of cyclic changes in the expression of endocrine gland vascular endothelial growth factor in the human corpus luteum.